# SITAGLIPTIN PHOSPHATE
> **ANDA202327** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2025-12-29
## Drug
- **FDA Application Number:** ANDA202327
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN PHOSPHATE
- **Generic name:** Sitagliptin Phosphate
- **Active ingredients:** SITAGLIPTIN PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS INC
- **First approval:** 2025-12-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202327)
---
*MORVS · CC0 1.0*